Reply for "Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy"

Noemi Lois; Vikki McBain; Ehab Abdelkader; Neil W. Scott; Reena Kumari

doi:10.1097/IAE.0b013e31829f3f0a

Reply for "Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy"

Noemi Lois, Vikki McBain, Ehab Abdelkader, Neil W. Scott, Reena Kumari

Research output: Contribution to journal › Letter › peer-review

Abstract

We would like to thank Dr. Rubowitz for his interest in our article entitled “Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy,” published in a very recent issue of Retina.1 We first described and presented the frequent occurrence of RPE atrophy, determined by fundus autofluorescence and near infrared autofluorescence, and its possible relationship with VEGF blockage at the Thirty-Fourth Annual Meeting of the Macula Society in March 2011. This observation followed on our previous work identifying very high rates of RPE atrophy in patients with retinal angiomatous proliferation undergoing, mostly, anti-VEGF treatment.2

Original language	English
Pages (from-to)	1998-1999
Number of pages	2
Journal	Retina
Volume	33
Issue number	9
DOIs	https://doi.org/10.1097/IAE.0b013e31829f3f0a
Publication status	Published - Oct 2013

Access to Document

10.1097/IAE.0b013e31829f3f0aLicence: Unspecified

Cite this

@article{13b0b2225a8446ba82e8b846e99a03ae,

title = "Reply for {"}Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy{"}",

abstract = "We would like to thank Dr. Rubowitz for his interest in our article entitled “Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy,” published in a very recent issue of Retina.1 We first described and presented the frequent occurrence of RPE atrophy, determined by fundus autofluorescence and near infrared autofluorescence, and its possible relationship with VEGF blockage at the Thirty-Fourth Annual Meeting of the Macula Society in March 2011. This observation followed on our previous work identifying very high rates of RPE atrophy in patients with retinal angiomatous proliferation undergoing, mostly, anti-VEGF treatment.2",

author = "Noemi Lois and Vikki McBain and Ehab Abdelkader and Scott, {Neil W.} and Reena Kumari",

year = "2013",

month = oct,

doi = "10.1097/IAE.0b013e31829f3f0a",

language = "English",

volume = "33",

pages = "1998--1999",

journal = "Retina",

issn = "0275-004X",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Reply for "Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy"

AU - Lois, Noemi

AU - McBain, Vikki

AU - Abdelkader, Ehab

AU - Scott, Neil W.

AU - Kumari, Reena

PY - 2013/10

Y1 - 2013/10

N2 - We would like to thank Dr. Rubowitz for his interest in our article entitled “Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy,” published in a very recent issue of Retina.1 We first described and presented the frequent occurrence of RPE atrophy, determined by fundus autofluorescence and near infrared autofluorescence, and its possible relationship with VEGF blockage at the Thirty-Fourth Annual Meeting of the Macula Society in March 2011. This observation followed on our previous work identifying very high rates of RPE atrophy in patients with retinal angiomatous proliferation undergoing, mostly, anti-VEGF treatment.2

AB - We would like to thank Dr. Rubowitz for his interest in our article entitled “Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy,” published in a very recent issue of Retina.1 We first described and presented the frequent occurrence of RPE atrophy, determined by fundus autofluorescence and near infrared autofluorescence, and its possible relationship with VEGF blockage at the Thirty-Fourth Annual Meeting of the Macula Society in March 2011. This observation followed on our previous work identifying very high rates of RPE atrophy in patients with retinal angiomatous proliferation undergoing, mostly, anti-VEGF treatment.2

UR - http://www.scopus.com/inward/record.url?scp=84885018987&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e31829f3f0a

DO - 10.1097/IAE.0b013e31829f3f0a

M3 - Letter

AN - SCOPUS:84885018987

SN - 0275-004X

VL - 33

SP - 1998

EP - 1999

JO - Retina

JF - Retina

IS - 9

ER -

Reply for "Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy"

Abstract

Access to Document

Other files and links

Fingerprint

Cite this